Skip to content

Clinical trials

Dyslipidemias trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Argentina Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20067
20111
20122
20131
20151
20171
20211
20221
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting2
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda10
Novartis Pharmaceuticals3
89bio, Inc.1
Abbott1
Amgen1
Daniel A. Siniawski1
Eli Lilly and Company1
GlaxoSmithKline1
Helios Salud1
Institute for Clinical Effectiveness and Health Policy1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias23
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Glucose Metabolism Disorders9
Hypercholesterolemia6
Hyperlipidemias5
Diabetes Mellitus, Lipoatrophic3
Atherosclerosis2
Cardiovascular Diseases2
Coronary Artery Disease2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.